Tag: Research

Study: Outpatient antibiotic management of appendicitis

Editor's Note Managing appendicitis with antibiotics on an outpatient basis shows promise as a safe, effective, lower-cost alternative to surgery, this study finds. Of 30 patients involved in the trial, 15 were randomized to antibiotics and 14 to appendectomy. A total of 14 patients in the antibiotic group were discharged from…

Read More

By: Judy Mathias
March 20, 2017
Share

Biologists identify drug combinations to overcome antibiotic resistant bacteria

Editor's Note A team of University of California, Los Angeles (UCLA) biologists have found that combinations of three different antibiotics can overcome a bacteria’s resistance, even when none of the three on its own or two together is effective, the February 7 UCLA Newsroom reports. The biologists created a mathematical…

Read More

By: Judy Mathias
February 8, 2017
Share

Study: New surgical mask traps, kills viruses

Editor's Note A University of Alberta engineering professor and colleagues have invented a surgical mask that traps and kills viruses by applying a salt formulation to the mask’s filter fibers, the January 5 ScienceDaily reports. When an aerosol droplet carrying a virus contacts the treated fibers, the droplet absorbs the…

Read More

By: Judy Mathias
January 17, 2017
Share

New RBC treatment may reduce transfusion side effects

Editor's Note Pretreating red blood cells (RBCs) with nitric oxide may reduce the risk of pulmonary hypertension, a dangerous side effect of transfusions, finds this study. The Food and Drug Administration allows transfusion of RBCs that have been stored for 42 days. However, recent studies suggest that transfusion of RBCs…

Read More

By: Judy Mathias
November 15, 2016
Share

Study links antibiotic resistance to chlorhexidine

Editor's Note This study from the UK is the first to link antibiotic resistance with exposure to the disinfectant chlorhexidine. In five of six strains of Klebsiella pneumoniae exposed to chlorhexidine-containing disinfectants in the laboratory, adaptation to chlorhexidine led to resistance to the last resort antibiotic colistin. The risk of…

Read More

By: Judy Mathias
November 9, 2016
Share

Study identifies high touch areas in the OR

Editor's Note This study from the University of Colorado Hospital, Centennial, found that the five primary high touch surfaces in the OR (in order) are: anesthesia computer mouse OR bed nurse computer mouse OR door anesthesia cart. The study also demonstrated that low touch areas were less contaminated than high…

Read More

By: Judy Mathias
November 2, 2016
Share

Harvard researchers create first 3-D printed heart-on-a-chip

Editor's Note Harvard researchers have created the first 3-D printed heart-on-a-chip capable of collecting data on how reliably a heart is beating, and how a heart responds to drugs and toxins, the October 25 Gizmodo reports. The 3-D printed organ is made of synthetic material designed to mimic the structure…

Read More

By: Judy Mathias
October 27, 2016
Share

Experimental nanofiber coating prevents prosthetic joint infections

Editor's Note In a study on mice, Johns Hopkins researchers have shown that a coating made with antibiotic-releasing nanofibers can prevent bacterial infections after total joint surgery. After 14 days, mice that received implants without the antibiotic coating all had bacteria in infected tissue around the joint, and 80% had…

Read More

By: Judy Mathias
October 25, 2016
Share

Comparative effectiveness of prostate cancer treatments

Editor's Note At 10 years, prostate cancer mortality was low irrespective of the treatment and with no significant difference among treatments, this study finds. Treatments included active monitoring (1.5 deaths/1,000 person years), radical prostatectomy (0.9 deaths/1,000 person years), and external-beam radiotherapy (0.7 deaths/1,000 person years). Surgery and radiotherapy were associated…

Read More

By: Judy Mathias
October 13, 2016
Share

First clinical trial of HCV-infected kidney transplants

Editor's Note Researchers at Penn Medicine, Philadelphia, are conducting a clinical trial to test the effect of administering antiviral therapy to organ recipients after being transplanted with kidneys infected with the hepatitis C virus (HCV). The first participant received a kidney transplant in July, and after being treated with Zepatier…

Read More

By: Judy Mathias
September 13, 2016
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat